Merck & Co. said a European Medicines Agency panel recommended expanded approval of the drugmaker's blockbuster cancer treatment Keytruda in two types of gynecologic cancers.

Deep-pocketed investors have adopted a bullish approach towards Merck & Co MRK, and it's something market players shouldn't ...

Thank you for attending our Global Healthcare Conference. Today, I have the pleasure to host Joe Romanelli, President of Human Health International; and Peter Dannenbaum, Head of Investor Relations.

Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a ...

Merck (NYSE:MRK) announced Wednesday that the U.S. Food and Drug Administration (FDA) approved a label expansion for its ...

Here are 10 of the best health care stocks to buy in 2024, according to CFRA analysts: *As of Sept. 10 close. Based on ...

Yakubison discusses his role at Merck & Co., Inc., Rahway, NJ, USA (hereinafter “MSD”), the evolution of pharmaceutical ...

Utopia has acquired U.S. rights to acclaimed director Alex Ross Perry’s (“Her Smell,” “Listen Up Philip”) “Pavements,” the day after its world premiere at the Venice Film Festival.

KIRKLAND, QC, Sept. 4, 2024 /CNW/ - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that WINREVAIR® (sotatercept) is now authorized for use in Canada in ...

Referencing Hipgnosis’ founder Merck Mercuriadis, who stepped down from the company earlier this year after its stock plunged, the lawsuit states: “Via its agent Merck Mercuradis, Hipgnosis ...

It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 5.6% over the past three months. But if you pay close attention, you might find that ...

Hipgnosis helped drive the music acquisition boom that dominated headlines in recent years as the company, formerly led by music manager Merck Mercuriadis, spent billions acquiring catalogs from ...